ENvue Medical announces 1-for-12 reverse stock split effective Sept 1, 2026

ENvue Medical, Inc.

Effective Sept 1, 2026 at 12:01 a.m. EDT; shares start trading split-adjusted on Nasdaq under FEED with new CUSIP 63008J876.
Outstanding shares reduce from 11,084,616 to approximately 923,718; each 12 shares combine into 1.
Authorized shares unchanged at 40,000,000; par value and preferred stock unaffected.
No fractional shares; any fractional shares rounded up to nearest whole share per stockholder.
Options, warrants, convertibles, and restricted stock adjusted by dividing share count by 12 and multiplying exercise price by 12.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.